The US-based medical search engine OpenEvidence is down in Europe: A commentary on regulatory complexities
Year: 2026
Type: article
Abstract: • US-based OpenEvidence withdrew from Europe citing AI Act uncertainty. • MDR Rule 11 may classify clinical AI search tools as Class IIa devices. • Medical AI using LLMs and RAG needs strict human-in-the-loop safeguards. • MDR compliance imposes heavy time and cost burdens on non-profit AI. • Regulatory sandboxes support AI innovation without lowering safety standards.
Source: Health Policy and Technology
Author: Vittorio De Vita
Institution: Università Cattolica del Sacro Cuore
Language: English
Topic: Healthcare Regulation
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,000
OpenAlex ID: W7166323480
